Aussie Team Uses Hot Ethanol to Make Smaller API Particles

By Gareth Macdonald

- Last updated on GMT

Related tags Pharmacology

Aussie Team Uses Hot Ethanol to Make Smaller Particles
Aussie Team Uses Hot Ethanol to Make Smaller Particles
Appreciating warm alcohol, like being rubbish at cricket, is no longer a solely British preserve with researchers in Australia developing a hot ethanol-based manufacturing method that, they claim, produces smaller, more uniform API particles.

At present, most drug particle production methods involve spraying droplets of a solution into a hot air environment where, after the liquid has dried, solid spheres of active pharmaceutical ingredient (API) are formed.

The problem is that the drying process is hard to control and yields API particles that vary in size and shape. This challenge prompted Dr Meng Wai Woo and his team at Monash University in Melbourne to start looking for alternatives and ultimately develop the new method, which is known as anti-solvent vapour precipitation.

Meng told in-Pharmatechnologist.com the approach "involves spraying the tiny drug droplets into mildly hot ethanol vapour environment [where] the particles are formed not due to drying but due to the solids becoming less soluble in the droplet, as the droplet absorbs the ethanol vapour.”

The scientists claim they can produce drug particles smaller than a micron in diameter, which is much smaller than those made using conventional dehydrating mechanisms that are limited by droplet size.

Manufacturing benefits

While these ultra-small particles could be used to develop for example more effective inhaled drug formulations, there are also potential advantages for manufacturers according to Meng.

The main economic benefit from this technique is that smaller and more uniform particles can potentially be produced without the need to use smaller atomizers to generate the droplets.​ 

This will translate to higher production rate and higher financial return from the process.  The new technique also negates the need for milling operation for particle size reduction, which is one of the current practices to make such ultrafine particles​.”

Demo development

The team has been using the ethanol-based approach to produce API particles in 2011 and first demonstrated the approach to drugmakers at the18th International Drying Symposium in Xiamen, China, last year.

The plan now is to further showcase the technology at industry event according to Meng, who set out the group’s strategy.

We are now developing a demonstration unit for this new process which is due to complete by the end of the year.  Once the demonstration unit is fully running, we will then invite pharmaceutical companies for further discussion on the tech​."

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...